The Cost-Effectiveness of Treatments for FND

I think it's important to take a very nuanced approach to these studies and what figures they're reporting. There are broader issues when you're trying to work out the cost-effectiveness of treatments for patients with FND. If you have a treatment approach based primarily on the presenting symptom, that can dilute or even obscure your treatment benefit for a subset of patients. So again, this needs to be thought about carefully when you're assessing the cost-effective. And finally, we know that FND is a chronic disorder, it's a fluctuating disorder, you really need long-term data here.